Mar 14, 2017 11:01 am UTC| Business
SAN DIEGO, March 14, 2017 -- Kratos Defense Security Solutions, Inc. (Nasdaq:KTOS), a leading National Security Solutions provider, announced today that its subsidiary, RT Logic, was awarded a contract from the prime...
Global Eagle and Norwegian Cruise Line Holdings Enter Strategic Partnership Agreement
Mar 14, 2017 11:01 am UTC| Business
LOS ANGELES, March 14, 2017 -- Global Eagle Entertainment Inc. (NASDAQ:ENT) (“Global Eagle” or “Company”) has signed a multi-year strategic partnership agreement with Norwegian Cruise Line Holdings (NCLH) to enhance...
Global Eagle and Norwegian Cruise Line Holdings Enter Strategic Partnership Agreement
Mar 14, 2017 11:01 am UTC| Business
LOS ANGELES, March 14, 2017 -- Global Eagle Entertainment Inc. (NASDAQ:ENT) (“Global Eagle” or “Company”) has signed a multi-year strategic partnership agreement with Norwegian Cruise Line Holdings (NCLH) to enhance...
Announcing NYIAX, the World’s First Advertising Contract Exchange
Mar 14, 2017 11:01 am UTC| Business
NYIAX aims to transform ad inventory into standardized and durable securities A blockchain-enabled media trading platform running in the cloud and powered by Nasdaq NEW YORK, March 14, 2017 -- Today, the world’s...
Announcing NYIAX, the World’s First Advertising Contract Exchange
Mar 14, 2017 11:01 am UTC| Business
NYIAX aims to transform ad inventory into standardized and durable securities A blockchain-enabled media trading platform running in the cloud and powered by Nasdaq NEW YORK, March 14, 2017 -- Today, the world’s...
Antares Pharma Reports Fourth Quarter and Full Year 2016 Operating and Financial Results
Mar 14, 2017 11:00 am UTC| Business
2016 Results Driven by Continued Growth in Product Sales and Significant Progress in Pipeline Programs Full Year Revenue of $52.2 Million Increased 14% Versus Prior Year EWING, N.J., March 14, 2017 -- Antares Pharma,...
Neos Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results
Mar 14, 2017 11:00 am UTC| Business
DALLAS and FORT WORTH, Texas, March 14, 2017 -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR) products using...